Lilly Partnership Integration under Eli Lilly creates a built-in channel for cross-selling development, manufacturing, and analytics services to Lilly units and related partners.

Scale-Up Needs Encapsulated-cell therapy programs require GMP manufacturing, process development, QA/QC, and tech transfer; position as a vendor for manufacturing scale-up and quality systems.

Data & Cloud Current tech stack shows AWS and data tools; propose offering integrated cloud data management, LIMS, and AI machine learning analytics to accelerate R&D and manufacturing decisions.

Pipeline Growth Long-standing collaboration with Lilly suggests opportunity to extend support into additional indications, clinical development, and regulatory strategy.

Funding Leverage Moderate revenue with solid external funding signals readiness to engage CRO/CMO, regulatory, and supplier partnerships to scale operations and bring therapies to market.